1. Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer
   Sara K. Jaradat et al, 2024, Technology in Cancer Research & Treatment CrossRef
2. Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer
   Rumeysa Ozyurt et al, 2023, Molecular Cancer Therapeutics CrossRef
3. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin
   Yuqi Xin et al, 2023, Aging CrossRef
4. AXL upregulates c‑Myc expression through AKT and ERK signaling pathways in breast cancers
   Xiaobai Sun et al, 2023, Molecular and Clinical Oncology CrossRef